Samsung Pharma receives US$3.8m order for anti-hangover products

Published : Jul 1, 2016 - 10:00 Updated : Jul 1, 2016 - 10:00

◀ Back to List
More article by this Writer

[DISCLOSURE] Samsung Pharmaceutical (001360) has signed a 4.4 billion won (US$3.8 million) contract with PICO Entech to supply anti-hangover products, it announced on July 1. This amounts to 10.44 percent of its recent revenue.

◀ Back to List
More article by this Writer

LATEST NEWS

>

Japan voices regret over S. Korea's non-attendance of Sado memorial
>

S. Korea not to attend Sado mine memorial: foreign ministry
>

[Weekender] Korea's traditional sauce culture gains global recognition
>

[What to Play] Cozy songs to warm you up
>

Toxins at 622 times legal limit found in kids' clothes from Chinese platforms
>

Gyeongju blends old with new
>

At Gwangcheonok, try North Korean-style sundae gukbap
>

Over 80,000 malicious calls made to Seoul call center since 2020
>

Trump picks ex-N. Korea policy official as his principal deputy national security adviser
>

BLACKPINK's Rose stays at No. 3 on British Official Singles chart with 'APT.'